SINTEZ OAO (P) |
End-of-day quote
Other stock markets
|
||
| - USD | - |
|
| 2013 | Hellenic Petroleum S.A. : Greece seals natural gas privatisation deal with Azeri company | RE |
| 2013 | Mytilineos Holdings S.A. : Greek gas firm privatisation fails in setback to bailout | RE |
Days
Hours
Minutes
Seconds
-40%
on all our subscriptions*
Take advantage of the offer
* See conditions on site
| Managers | Title | Age | Since |
|---|---|---|---|
| Director of Finance/CFO | - | - | |
| Chief Tech/Sci/R&D Officer | - | - | |
M. V. Bavkunova
AUD | Comptroller/Controller/Auditor | - | - |
| Members of the board | Title | Age | Since |
|---|---|---|---|
| Director/Board Member | 75 | - | |
| Director/Board Member | 63 | 15-06-30 | |
| Director/Board Member | - | 15-06-30 |
Sintez OAO, also known as Sintez OAO or Sintez Kurgansk Pharmaceutical and Medical Drug Company OJSC, is a Russia-based company engaged in the pharmaceutical industry business sector. Its products portfolio includes tablets, capsules, ampoules, drops, creams, gels, antibiotics, as well as plastic facilities for blood testing and transfusion and products for preserving blood and medicines for veterinary use, among others. The drugs produced by the Company are AzitRus, Almorus, Amosin, Arlet, Atsekardol, Bifosin, Bitsillin, Bronhorus, Vankorus, Vedikardol, Leflobakt and Lofoks, among others. The Company's main shareholder is Clinolina Holdings Limited. It also operates through three subsidiaries: Sintez PV OOO, Sintez Atseton OOO and Sintez Servis-1 OOO.
Sector
Pharmaceuticals
| 1st Jan change | Capi. | |
|---|---|---|
| +19.98% | 43.48B | |
| +20.67% | 22.65B | |
| +14.56% | 14.73B | |
| +14.32% | 13.79B | |
| +44.72% | 12.04B | |
| -8.37% | 7.08B | |
| -0.05% | 6.79B | |
| -8.87% | 5.73B | |
| +11.90% | 5.47B |
- Stock Market
- Equities
- Stock
